1型神经纤维瘤病中嗜铬细胞瘤的可乐定抑制试验
Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1.
作者信息
Wan WingYee, Nguyen Bichle, Graybill Sky, Kim Jonathan
机构信息
Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
Endocrinology Department, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
出版信息
BMJ Case Rep. 2019 Jun 25;12(6):e228263. doi: 10.1136/bcr-2018-228263.
Abstract
Compared with the general population, rates of pheochromocytoma are higher in neurofibromatosis type 1 (NF1) patients. However, pheochromocytoma testing is often plagued by false positive results. Here we present a patient with NF1, elevated urinary metanephrine levels, and an indeterminate adrenal nodule. Clonidine suppression testing aided diagnosis and led to definitive surgical treatment that confirmed a pheochromocytoma. Pheochromocytoma screening and clonidine suppression testing can both aid in the evaluation for catecholamine-secreting tumours.
摘要
与普通人群相比，1型神经纤维瘤病（NF1）患者的嗜铬细胞瘤发病率更高。然而，嗜铬细胞瘤检测常常受到假阳性结果的困扰。在此，我们报告1例患有NF1、尿间甲肾上腺素水平升高且肾上腺结节性质不明的患者。可乐定抑制试验有助于诊断，并最终促成了确定性手术治疗，确诊为嗜铬细胞瘤。嗜铬细胞瘤筛查和可乐定抑制试验均有助于评估儿茶酚胺分泌性肿瘤。
相似文献
1
Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1.1型神经纤维瘤病中嗜铬细胞瘤的可乐定抑制试验
BMJ Case Rep. 2019 Jun 25;12(6):e228263. doi: 10.1136/bcr-2018-228263.
2
The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements.用于诊断嗜铬细胞瘤的可乐定试验：尿间甲肾上腺素测量的效用。
Braz J Med Biol Res. 1987;20(1):43-6.
3
Current concepts. Pheochromocytoma: diagnosis, localization and management.当前概念。嗜铬细胞瘤：诊断、定位与管理。
N Engl J Med. 1984 Nov 15;311(20):1298-303. doi: 10.1056/NEJM198411153112007.
4
Pheochromocytoma: a disease with many faces.
Isr Med Assoc J. 2002 Oct;4(10):817-8.
5
Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.用于诊断嗜铬细胞瘤的尿可乐定抑制试验。
J Hypertens. 2015 Nov;33(11):2286-93. doi: 10.1097/HJH.0000000000000705.
6
Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.嗜铬细胞瘤的生化诊断：如何区分真阳性与假阳性检测结果。
J Clin Endocrinol Metab. 2003 Jun;88(6):2656-66. doi: 10.1210/jc.2002-030005.
7
Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels.血浆儿茶酚胺水平正常的患者可乐定抑制试验的特异性降低。
Am J Med. 1988 Mar;84(3 Pt 1):419-24. doi: 10.1016/0002-9343(88)90261-6.
8
Pheochromocytoma: recent experience with detection and management.嗜铬细胞瘤：检测与管理的近期经验
Urology. 1977 Aug;10(2):133-8. doi: 10.1016/0090-4295(77)90011-5.
9
[Pheochromocytoma associated with neurofibromatosis 1: a report of two cases].[与1型神经纤维瘤病相关的嗜铬细胞瘤：两例报告]
Hinyokika Kiyo. 2005 Dec;51(12):793-5.
10
Different diagnostic cut-off values of urinary fractionated metanephrines according to sex for the diagnosis of pheochromocytoma in Korean subjects.不同性别尿游离甲氧基肾上腺素的诊断截断值在韩国人群中用于嗜铬细胞瘤的诊断。
Endocr J. 2012;59(9):831-8. doi: 10.1507/endocrj.ej12-0052. Epub 2012 Jun 14.
引用本文的文献
1
Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment.嗜铬细胞瘤：从临床表现到管理与治疗的最新范围综述
Front Endocrinol (Lausanne). 2024 Dec 13;15:1433582. doi: 10.3389/fendo.2024.1433582. eCollection 2024.
2
Mutational Spectrum and Genotype-phenotype Correlations in Neurofibromatosis Type 1 Patients from North Macedonia: Identification of Ten Novel Pathogenic Variants.NF1 患者的突变谱和基因型-表型相关性：十种新的致病性变异的鉴定。
Balkan Med J. 2023 Jul 12;40(4):252-261. doi: 10.4274/balkanmedj.galenos.2023.2022-12-28. Epub 2023 Apr 19.
本文引用的文献
1
Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening.1型神经纤维瘤病中的嗜铬细胞瘤和副神经节瘤：频繁手术和心血管危机表明需要进行筛查。
Clin Diabetes Endocrinol. 2018 Jun 22;4:15. doi: 10.1186/s40842-018-0065-4. eCollection 2018.
2
The importance of pheochromocytoma case detection in patients with neurofibromatosis type 1: A case report and review of literature.1型神经纤维瘤病患者中嗜铬细胞瘤病例检测的重要性：一例病例报告及文献综述
SAGE Open Med Case Rep. 2017 Nov 16;5:2050313X17741016. doi: 10.1177/2050313X17741016. eCollection 2017.
3
Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1.对1型神经纤维瘤病患者进行嗜铬细胞瘤系统筛查的意义。
Eur J Endocrinol. 2016 Oct;175(4):335-44. doi: 10.1530/EJE-16-0233. Epub 2016 Jul 22.
4
Neurofibromatosis type 1 associated with pheochromocytoma and gastrointestinal stromal tumors: A case report and literature review.1型神经纤维瘤病合并嗜铬细胞瘤和胃肠道间质瘤：1例报告及文献复习
Oncol Lett. 2016 Jul;12(1):637-643. doi: 10.3892/ol.2016.4670. Epub 2016 Jun 1.
5
Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension.一名高血压患者同时患有嗜铬细胞瘤和1型神经纤维瘤病
Open Access Maced J Med Sci. 2015 Dec 15;3(4):713-6. doi: 10.3889/oamjms.2015.130. Epub 2015 Dec 6.
6
Catecholamine excess: pseudopheochromocytoma and beyond.儿茶酚胺过量：假性嗜铬细胞瘤及其他。
Adv Chronic Kidney Dis. 2015 May;22(3):218-23. doi: 10.1053/j.ackd.2014.11.002.
7
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.嗜铬细胞瘤和副神经节瘤：内分泌学会临床实践指南
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42. doi: 10.1210/jc.2014-1498.
8
Neurofibromatosis type 1, pheochromocytoma with primary hyperparathyroidism: A rare association.1型神经纤维瘤病合并嗜铬细胞瘤及原发性甲状旁腺功能亢进：一种罕见的关联。
Indian J Endocrinol Metab. 2013 Mar;17(2):349-51. doi: 10.4103/2230-8210.109670.
9
Type 1 neurofibromatosis and pheochromocytoma: Focus on hypertension.1型神经纤维瘤病与嗜铬细胞瘤：聚焦于高血压。
J Neurosci Rural Pract. 2012 Jan;3(1):107-8. doi: 10.4103/0976-3147.91987.
10
Neurofibromatosis 1 with pheochromocytoma.1型神经纤维瘤病合并嗜铬细胞瘤
Indian J Endocrinol Metab. 2011 Oct;15 Suppl 4(Suppl4):S406-8. doi: 10.4103/2230-8210.86988.
Zotero 插件